Cargando…

Evaluation of Candidate Biomarkers of Type 1 Diabetes via the Core for Assay Validation

Recognizing an increasing need for biomarkers that predict clinical outcomes in type 1 diabetes (T1D), JDRF, a major funding organization for T1D research, recently instituted the Core for Assay Validation (CAV) to accelerate the translation of promising assays from discovery to clinical implementat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Speake, Cate, Odegard, Jared M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589091/ https://www.ncbi.nlm.nih.gov/pubmed/26462120 http://dx.doi.org/10.4137/BMI.S29697

Ejemplares similares

The many faces of islet antigen‐specific CD8 T cells: clues to clinical outcome in type 1 diabetes
por: Wiedeman, Alice E, et al.
Publicado: (2021)

A standardized metric to enhance clinical trial design and outcome interpretation in type 1 diabetes
por: Ylescupidez, Alyssa, et al.
Publicado: (2023)

The Relationship of Immune Cell Signatures to Patient Survival Varies within and between Tumor Types
por: Linsley, Peter S., et al.
Publicado: (2015)

ABCC8-Related Monogenic Diabetes Presenting Like Type 1 Diabetes in an Adolescent
por: Grier, Alexandra E., et al.
Publicado: (2023)

Proteomic analysis to identify candidate biomarkers associated with type 1 diabetes
por: do Nascimento de Oliveira, Valzimeire, et al.
Publicado: (2018)

A guide to kernel exploitation: attacking the core
por: Perla, Enrico, et al.
Publicado: (2011)

Candidate Glycoprotein Biomarkers for Canine Visceral Hemangiosarcoma and Validation Using Semi-Quantitative Lectin/Immunohistochemical Assays
por: Oungsakul, Patharee, et al.
Publicado: (2021)

Candidate Biomarkers for the Prediction and Monitoring of Partial Remission in Pediatric Type 1 Diabetes
por: Gomez-Muñoz, Laia, et al.
Publicado: (2022)

Shifts in isoform usage underlie transcriptional differences in regulatory T cells in type 1 diabetes
por: Newman, Jeremy R. B., et al.
Publicado: (2023)

Recognition of Posttranslationally Modified GAD65 Epitopes in Subjects With Type 1 Diabetes
por: McGinty, John W., et al.
Publicado: (2014)

Systematic Assessment of Immune Marker Variation in Type 1 Diabetes: A Prospective Longitudinal Study
por: Speake, Cate, et al.
Publicado: (2019)

Malaria sporozoite proteome leaves a trail
por: Vignali, Marissa, et al.
Publicado: (2009)

Validation of biomarkers of food intake—critical assessment of candidate biomarkers
por: Dragsted, L. O., et al.
Publicado: (2018)

Response to Comment on So et al. Autoantibody Reversion: Changing Risk Categories in Multiple-Autoantibody–Positive Individuals. Diabetes Care 2020;43:913–917
por: So, Michelle, et al.
Publicado: (2020)

Copy Number Loss of the Interferon Gene Cluster in Melanomas Is Linked to Reduced T Cell Infiltrate and Poor Patient Prognosis
por: Linsley, Peter S., et al.
Publicado: (2014)

Identification of candidate biomarkers and pathways associated with type 1 diabetes mellitus using bioinformatics analysis
por: Pujar, Madhu, et al.
Publicado: (2022)

Innate immune activity as a predictor of persistent insulin secretion and association with responsiveness to CTLA4-Ig treatment in recent-onset type 1 diabetes
por: Cabrera, Susanne M., et al.
Publicado: (2018)

Identification and validation of candidate epigenetic biomarkers in lung adenocarcinoma
por: Daugaard, Iben, et al.
Publicado: (2016)

Development and validation of novel biomarker assays for osteoarthritis
por: Ourradi, Khadija, et al.
Publicado: (2017)

Metabolomic comparison followed by cross-validation of enzyme-linked immunosorbent assay to reveal potential biomarkers of diabetic retinopathy in Chinese with type 2 diabetes
por: Wang, Zongyi, et al.
Publicado: (2022)

Quantitative iTRAQ-Based Proteomic Identification of Candidate Biomarkers for Diabetic Nephropathy in Plasma of Type 1 Diabetic Patients
por: Overgaard, Anne Julie, et al.
Publicado: (2010)

Assay Validation for KIM-1: human urinary renal dysfunction biomarker
por: Chaturvedi, Shalini, et al.
Publicado: (2009)

Validity and Reproducibility of Measurement of Islet Autoreactivity by T-Cell Assays in Subjects With Early Type 1 Diabetes
por: Herold, Kevan C., et al.
Publicado: (2009)

Integrative analysis to select cancer candidate biomarkers to targeted validation
por: Kawahara, Rebeca, et al.
Publicado: (2015)

Validation of Candidate Serum Ovarian Cancer Biomarkers for Early Detection
por: Su, Feng, et al.
Publicado: (2007)

Drug-Induced Liver Injury: Biomarkers, Requirements, Candidates, and Validation
por: Meunier, Lucy, et al.
Publicado: (2019)

Tumor type classification and candidate cancer-specific biomarkers discovery via semi-supervised learning
por: Chen, Peng, et al.
Publicado: (2023)

Comparison of Protein Immunoprecipitation-Multiple Reaction Monitoring with ELISA for Assay of Biomarker Candidates in Plasma
por: Lin, De, et al.
Publicado: (2013)

Recent results of exenatide use as adjunctive therapy in the treatment of patients with type 2 diabetes
por: Odegard, Peggy Soule, et al.
Publicado: (2009)

iTRAQ plasma proteomics analysis for candidate biomarkers of type 2 incipient diabetic nephropathy
por: Lu, Hongmei, et al.
Publicado: (2019)

Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes
por: Sims, Emily K., et al.
Publicado: (2019)

Identification of Core Gene Biomarkers in Patients with Diabetic Cardiomyopathy
por: Li, Ning, et al.
Publicado: (2018)

Screening and identification of novel candidate biomarkers of focal cortical dysplasia type II via bioinformatics analysis
por: Wang, Jiang-ya, et al.
Publicado: (2022)

Autoreactive T cell receptors with shared germline-like α chains in type 1 diabetes
por: Linsley, Peter S., et al.
Publicado: (2021)

Postprandial insulin assay as the earliest biomarker for diagnosing pre-diabetes, type 2 diabetes and increased cardiovascular risk
por: DiNicolantonio, James J, et al.
Publicado: (2017)

Identification of Core Prognosis-Related Candidate Genes in Cervical Cancer via Integrated Bioinformatical Analysis
por: Wei, Jianxia, et al.
Publicado: (2020)

Validating candidate biomarkers for different stages of non-alcoholic fatty liver disease
por: Al-Qarni, Reem, et al.
Publicado: (2020)

Characterization of New Proteomic Biomarker Candidates in Mucopolysaccharidosis Type IVA
por: Álvarez, Víctor J., et al.
Publicado: (2020)

New Wild-Type Lacticaseibacillus rhamnosus Strains as Candidates to Manage Type 1 Diabetes
por: Nelios, Grigorios, et al.
Publicado: (2022)

Identification of Novel Pre-Erythrocytic Malaria Antigen Candidates for Combination Vaccines with Circumsporozoite Protein
por: Speake, Cate, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_i7qg41ptc49itgfjqaiu50l6t1